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Abstract
Purpose of Review Circadian rhythms, including 24-h activity rhythms, change with age. Disturbances in these 24-h activity
rhythms at older age have also been implied in various diseases. This review evaluates recent findings on 24-h activity rhythms
and disease in older adults.
Recent Findings Growing evidence supports that 24-h activity rhythm disturbances at older age are related to the presence and/or
progression of disease. Longitudinal and genetic work even suggests a potential causal contribution of disturbed 24-h activity
rhythms to disease development. Interventional studies targeting circadian and 24-h activity rhythms demonstrate that 24-h
rhythmicity can be improved, but the effect of improving 24-h rhythmicity on disease risk or progression remains to be shown.
Summary Increasing evidence suggests that 24-h activity rhythms are involved in age-related diseases. Further studies are
needed to assess causality, underlying mechanisms, and the effects of treating disturbed 24-h activity rhythms on age-related
disease.
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Introduction
The circadian rhythm is integral to physiological processes
throughout the body [1]. These approximately 24-h rhythms
are regulated by the master clock located in the brain’s supra-
chiasmatic nucleus (SCN) [2], and are shaped using endoge-
nous and exogenous cues. Together, this ensures that our
physiological functioning can be optimized and adapted to
changing environmental conditions and social demands [3].
Circadian rhythms can be observed in a range of physio-
logical and behavioral processes throughout the body, for ex-
ample, fluctuations in clock gene expression, hormone levels,
body temperature, and cognitive processes [1]. Although
many of these fluctuations are valid and precise markers of
the circadian rhythm, they are often less feasible to study
when the circadian rhythm needs to be assessed over longer
periods of time or in large populations. An accessible, afford-
able, and unobtrusive alternative to measure 24-h rhythmicity
is actigraphy, also known as accelerometry. Actigraphy can
measure activity continuously over multiple days, weeks, or
even months. Naturally, activity is under voluntary control
and may therefore misrepresent some of the underlying en-
dogenous rhythms. Yet, measuring 24-h activity rhythms with
actigraphy has been demonstrated to be a valid method to
estimate circadian rhythmicity, in both patients and healthy
adults [1, 4]. With ever increasing recording quality, better
storage capacities, longer recording lengths, and the availabil-
ity of open source algorithms, actigraphy has become a main-
stay for studying circadian rhythms in research and clinical
practice [5•, 6].
Circadian rhythms, and associated 24-h activity rhythms,
are altered with increasing age [1, 7•]. Older age is also ac-
companied by an increase in the prevalence of non-
communicable diseases [8]. It has been hypothesized that
changes in 24-h activity rhythms might indicate poor health
or even pose a risk factor for poor health, not the least because
fragmented 24-h activity rhythms have been associated with
an increased risk of mortality [9]. As modern 24/7 society puts
a widespread strain on our rhythms, for example, through
artificial lighting and shift work, it is crucial to better under-
stand the role of 24-h activity rhythm disturbance in the de-
velopment of age-related disease. In this review, we will brief-
ly discuss the measurement of 24-h activity rhythms, give a
short overview of age-related changes in 24-h activity
rhythms, and discuss recent findings around 24-h activity
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rhythms and some of the most common diseases in older
adults.
Measuring the 24-h Activity Rhythm
A range of scientific grade actigraphs, typically worn around
the wrist, has become available over the past decades. Starting
with relatively simple devices measuring activity on one axis,
nowadays, almost all actigraphs measure movement on three
axes and are equipped with additional sensors measuring tem-
perature, light, and/or heart rate. Typically, only the activity
data has been used to estimate the 24-h rhythm. Multiple com-
mercial wearables that measure activity have also become
available; their value in assessing 24-h activity rhythms re-
mains to be determined [10].
Several methods have been developed to derive 24-h rhyth-
micity estimates from actigraphy [4, 11••, 12••]; the most used
methods are based on adapted cosinor models [4, 11••] and
non-parametric models [12••]. From these models, a range of
24-h activity rhythm estimates is calculated, which are corre-
lated to some extent [13]. Both methods come with their own
set of advantages and disadvantages. For example, non-
parametric measures have been suggested to better reflect
24-h rhythms in elderly persons, because rhythms are gener-
ally less cosine shaped in older adults [12••]. In contrast,
cosinor measures seem to be associated more consistently
with outcomes such as cognitive functioning [14]. A descrip-
tion of the most commonly used cosinor and non-parametric
estimates can be found in Table 1.
24-h Activity Rhythms and Aging
Old age is accompanied by multiple changes in the 24-h ac-
tivity rhythm, including a well-described phase advance [13].
In recent work, a lower amplitude, lower mesor, earlier
acrophase, and more fragmented rhythm have been described
in older adults [6, 9, 15•, 16, 17]. Daytime activity levels are
also lower at old age [18], but nighttime activity levels do not
necessarily change in old age [19]. The stability of the 24-h
activity rhythm seems to remain similar across ages [16], and
has even been suggested to be higher in old age [20]. A recent
study in 91,105 individuals suggested that age was not asso-
ciated with relative amplitude [21•], but this study only includ-
ed persons aged 73 or younger. This fits previous suggestions
that 24-h activity rhythm disturbances are most pronounced in
those aged 80 years or older [9, 16].
Older and more recent studies thus both demonstrate that
middle-aged and elderly persons have “dampened” and less
robust 24-h activity rhythms [6], similar to alterations seen in
endogenous measures of the circadian rhythm at older age [1].
It is largely unknown to what extent these changes may be
attributed to the aging process per se. They could also be
caused by environmental changes that accompany older age,
such as retirement, less physical activity, or the emergence of
age-related diseases. Probably, a combination of endogenous
and exogenous factors plays a role in age-related changes in
the 24-h activity rhythm [1].
24-h Activity Rhythms
and Neurodegenerative Disease
Over the last 3 years, neurodegenerative disease has been the
most studied disease in relation to 24-h activity rhythms.
Indeed, circadian disturbances, including disrupted 24-h ac-
tivity rhythms, are common in neurodegenerative disease [5•,
22, 23]. These disturbances are potentially attributable to neu-
rodegenerative processes directly affecting circadian regulato-
ry circuits [2, 24], or indirectly through behavioral symptoms
impairing daily functioning and inadequate exposure to
Table 1 Commonly used cosinor
and non-parametric 24-h activity
rhythm estimates [4, 11••, 12••]
Variable Explanation
Cosinor
Acrophase Timing of maximum activity (clock time)
Amplitude Difference between maximum and minimum value of activity (score)
Mesor Average activity (counts/min)
Period Time interval over which cycles repeat (hours)
Pseudo-F Fit of activity data to the cosine function, indicating rhythm “robustness” (score)
Non-parametric
Interdaily variability Fragmentation of the rhythm relative to its 24-h amplitude (score)
Intradaily stability Stability of activity profiles over days (score)
Relative amplitude Normalized difference between most active 10 h and least active 5 h (score)
M10 onset Onset of most active 10-h period (clock time)
L5 onset Onset of least active 5-h period (clock time)
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exogenous cues. Vice versa, disturbed circadian rhythms have
also been hypothesized to contribute to neurodegenerative
processes [5•]. In the next paragraphs, we will focus on recent
findings on the role of 24-h activity rhythm disturbances in
Alzheimer’s disease and other dementias, and Parkinson’s
disease.
Alzheimer’s Disease and Dementia
Dementia, of which Alzheimer’s disease is the most common
subtype, is characterized by progressive cognitive decline and
impairment in activities of daily living [25]. Disruptions of
24-h activity rhythms in these patients were first recorded over
two decades ago [26], and have been reviewed recently [5•,
14, 27]. These disruptions predominantly include fragmenta-
tion and a reduced amplitude of the 24-h activity rhythm, and
behaviors such as “sun-downing” [27] and frequent daytime
napping [28]. Recent cross-sectional studies report a lower
amplitude [28–30], a lower stability [29, 31], and more frag-
mentation [29] in patients with dementia. More fragmented
24-h activity rhythms were also found in persons with early-
onset dementia [32]. Together, these disturbances substantial-
ly impair quality of life of patients and caregivers [33•, 34] and
are thought to be an important determinant for the institution-
alization of patients [27].
Research increasingly focuses on the pre-diagnostic phase
of dementia to investigate the potential etiological or predic-
tive role that 24-h activity rhythm disturbances may have in
dementia. Two recent studies investigated persons with poten-
tial prodromal symptoms of dementia, but no evidence was
found for an association of phase with subjective cognitive
complaints [35] or of amplitude with mild cognitive impair-
ment [30]. This was even though the latter was found to be
disturbed in those with Alzheimer’s disease [30]. In contrast,
some earlier studies have reported a phase advance in persons
with mild cognitive impairment compared with healthy con-
trols [36, 37] and a higher fragmentation and lower mesor in
those with preclinical AD [16]. Data from prospective cohorts
provide some further insight into the temporality of the asso-
ciation of 24-h activity rhythms with dementia. An advanced
acrophase was associated with an increased risk of cognitive
decline in elderly men [15•], whereas in elderly women, a
phase delay and lower robustness of the rhythm were associ-
ated with an increased risk of dementia and mild cognitive
impairment [38]. A higher fragmentation was also related with
a decline in cognition measured over the prior 12 years [39•].
Associations of 24-h activity rhythms with biomarkers of
neurodegeneration in non-demented individuals have been in-
vestigated to shed further light on the link between 24-h ac-
tivity rhythms and dementia. First, fragmentation was most
strongly related to a cerebrospinal fluid biomarker profile in-
dicative of Alzheimer’s disease, when compared with other
disturbances [16]. Additionally, fragmentation was related to
temporal lobe atrophy in cognitively unimpaired persons [29]
and to loss of gray matter in parietal regions specific to early
accumulation of Alzheimer’s pathology [39•]. Further re-
search remains needed to determine whether 24-h activity
rhythm estimates could also serve as a valid biomarker for
dementia.
Parkinson’s Disease
In Parkinson’s disease, which has a notable association with
REM sleep behavior disorder [5•], 24-h activity rhythm distur-
bances have been hypothesized to occur early in the disease
process and to potentially contribute to various symptoms and
pathological processes specific to Parkinson’s disease [40].
Patients have a higher fragmentation, lower stability, lower am-
plitude, and lower mesor than healthy controls [40–42]. A low
stability is also associated with poorer cognitive performance in
Parkinson’s disease [42]. It is unclear to what extent the 24-h
activity rhythm estimates are affected by impaired motor func-
tioning associated with the Parkinson’s disease diagnosis or
dopaminergic treatments for Parkinson’s disease [5•].
The longitudinal relation of 24-h activity rhythms with inci-
dent Parkinson’s disease has received limited attention so far,
but a recent study with 11 years of follow-up showed that day-
time actigraphy-estimated inactivity, indicative of “napping,”
was associated with increased risk of Parkinson’s disease [43].
Longitudinal studies assessing 24-h activity rhythms in relation
to Parkinson’s disease in particular, and neurodegenerative dis-
ease more broadly, are therefore highly needed.
24-h Activity Rhythms and Late-Life
Psychiatric Disease
Disturbances in 24-h activity rhythms are related to a range of
psychiatric disorders such as depression, anxiety, psychosis,
and schizophrenia [44•, 45•], of which some are also common
in old age. Depression is of specific interest in the context of
this review as a second peak in the prevalence of depression
starts around the age of 60 years. Depression, characterized by
a depressed mood or a loss of pleasure as a key symptom, and
additionally symptoms such as weight change, changes in
sleep, psychomotor agitation/retardation, fatigue, worthless-
ness, cognitive complaints, or suicidality [46], has a major
impact on global health [47].
Depression
Patients diagnosed with major depressive disorder have a ten-
dency to eveningness, delayed 24-h activity rhythms, a damp-
ened amplitude, and a lower mesor [17, 48•, 49–51].
Disturbed 24-h activity rhythms are also related with the se-
verity of depressive symptoms, even when symptoms are of a
Curr Sleep Medicine Rep (2020) 6:76–8378
subclinical level, which is common in elderly persons. A
cross-sectional population-based study of middle-aged and
elderly persons found an association of a lower stability and
higher fragmentation of the 24-h activity rhythm with more
depressive symptoms [20, 52]. A preference for eveningness
and a phase delay were also associated with severity of de-
pressive symptoms [53, 54]. Potentially, the association of
24-h activity rhythms and depressive symptoms differs be-
tween men and women; in one study, associations of disturbed
24-h activity rhythms with depressive symptoms were found
in men but not in women [55].
Increasing evidence supports that disturbances in the 24-h
activity rhythm not only are apparent during the depressive
episode, but might also precede depressive episodes or may
persist afterwards [49]. A recent UK Biobank study suggested
a lower relative amplitude in those with a retrospectively de-
termined lifetime incidence of major depressive disorder, bi-
polar disorder, and mood instability [21•]. A longitudinal
study in elderly men reported that both a late acrophase alone
and the combination of an early acrophase with a dampened
24-h activity rhythm amplitude were associated with a faster
increase in depressive symptoms over time [56]. Additionally,
a genome-wide association study (GWAS) including 71,500
participants reported a possible association between genetic
risk of a low relative amplitude and mood disorders [45•].
It remains unclear to what extent associations between dis-
turbances of 24-h activity rhythms and mental health are due
to medication use [44•, 57]. There is evidence that these asso-
ciations are independent of medication use [56], but we also
know that some 24-h activity rhythm disturbances are related
to medication use. For example, eveningness and phase delay
potentially hamper the efficacy of antidepressants [58, 59•],
and ketamine might improve 24-h activity rhythms, indepen-
dent of its effect on mood [60].
Other Psychiatric Disorders in Late Life
Bipolar disorders, in which the depressive episodes are ac-
companied by manic episodes, have also been related to dis-
turbances in the 24-h activity rhythm. Associations seem to be
state-dependent, with depressive episodes being accompanied
by a phase delay and manic episodes being accompanied by a
phase advance [61, 62]. However, the disturbances in the 24-h
activity rhythms might not only be a state marker as the phase
advance of 24-h activity rhythms and lower mesor may persist
after successful treatment of bipolar disorder [44].
For anxiety, relatively common at older age, it was shown
that more fragmented 24-h activity rhythms were associated
with higher odds of having an anxiety disorder [52], and that
lower activity levels and a lower mesor were associated with
current anxiety [48]. Additionally, disrupted 24-h activity
rhythms have also been linked to more suicidal behaviors
[63, 64], but the causality of this association remains to be
determined. Although actigraphy has been used in patients
with schizophrenia, 24-h rhythmicity has not often been
assessed [65]. Only one study assessed 24-h activity rhythms
and did not find an association of 24-h rhythm estimates with
positive or negative symptoms of schizophrenia [66].
24-h Activity Rhythms and Other Age-Related
Diseases
Aging is accompanied by an increase in other non-
communicable diseases such as type 2 diabetes, cardiovascu-
lar disease, and cancer [8], which have also been suggested to
involve circadian and 24-h activity rhythm disturbances [1,
50].
Cardio-Metabolic Disease
Cross-sectional studies reported prolonged napping [67], a low-
er amplitude [68], less stable [20, 68, 69], and more fragmented
[20] 24-h activity rhythms in middle-aged and elderly persons
with a higher body mass index, a well-known risk factor for
cardio-metabolic disease. Additionally, less stable 24-h activity
rhythms were associated with increased odds of metabolic syn-
drome and hypertension in elderly women [69]. Longitudinal
work suggests that 24-h activity rhythm disturbances might
already be apparent early on. A longitudinal population-based
study reported that a lower robustness of the rhythm and a lower
amplitude were associated with an increased risk of overall
cardiovascular disease, and that a lower mesor was associated
with an increased risk of coronary heart disease [70•]. It has also
been repeatedly shown that shift work is a risk factor for cardio-
metabolic disease, such as type 2 diabetes, obesity, and coro-
nary artery disease [50, 71, 72]; the 24-h activity rhythm has
however not been assessed in these studies. Most of these find-
ings have been based on observational studies, making it diffi-
cult to determine the underlying mechanisms. Experimental
studies in humans do however suggest that short-term circadian
misalignment already affects biomarkers for metabolic disease,
such as systolic blood pressure and preclinical states of diabetes
[73, 74].
Cancer
Disturbed 24-h activity rhythms are also seen in those suffer-
ing from cancer. A study in palliative cancer care reported that
24-h activity rhythms are more disrupted towards the end of
life [75]. Several recent studies also reported an association
between 24-h activity rhythm disturbance and cancer-related
mortality, most prominently in lung cancer patients, where
early mortality risks were up to 4 times higher in patients with
disrupted 24-h activity rhythms compared with those with
robust rhythms [76•, 77]. More disturbed 24-h activity
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rhythms were also associated with a shorter survival time in
patients suffering from head and neck cancers [78] and pa-
tients receiving palliative cancer care [75]. Cancer treatment
also seems to affect the 24-h activity rhythm; a recent longi-
tudinal study showed that several 24-h activity rhythm esti-
mates, including amplitude, worsen with each cycle of che-
motherapy in women with breast cancer [79].
Research Agenda
Collectively, these studies suggest that with older age,
24-h activity rhythms are dampened, more fragmented,
and more advanced. The presence of 24-h activity rhythm
disturbances is associated with various age-related dis-
eases. Most evidence is available for dementia and de-
pression but these have also been the most studied dis-
eases in relation to 24-h activity rhythms. Associations
between the 24-h activity rhythm and disease also differ
per 24-h activity rhythm estimate, which creates a com-
plex picture. Only a minority of studies has investigated
the association of 24-h activity rhythms and health longi-
tudinally, which limits our knowledge on the temporality
of associations between 24-h rhythm disturbances and
age-related disease. Although there is some evidence for
a possible causal role of 24-h activity rhythms in disease
at old age, more definitive evidence needs to be generated
with sophisticated analyses methods in prospective cohort
studies and intervention studies.
Studies specifically intervening on circadian rhythms that
take into account the 24-h activity rhythm remain scarce. A
number of studies have reported reduced circadian disrup-
tion after bright light therapy in patients with dementia [80],
Parkinson’s disease [81], depression [82], cardiovascular dis-
ease [83], and cancer [84]. However, it is largely unknown
to what extent intervening on circadian factors and, subse-
quently 24-h activity rhythms, improves relevant clinical
outcomes such as disease progression or mortality. So far,
we do know that interventions focusing on advancing circa-
dian timing, such as early morning bright light therapy, have
a positive effect on mood. Bright light therapy decreases
depression severity in depressed patients [82], and 8 weeks
of dawn-dusk stimulation improved mood and reduced anx-
iety in elderly persons living in a care home [85]. It remains
to be determined if improvement in 24-h activity rhythms is
a mediating factor.
Together, we feel that three items are essential to add to
the research agenda to improve our understanding of the
role of 24-h activity rhythms in health at older age. First,
implementation of actigraphy in prospective cohort studies
has not only been proven feasible, it is also needed to inves-
tigate temporality. It particularly creates a unique opportu-
nity if the 24-h activity rhythm disturbances can be studied
before the diagnosis of the disease in population-based co-
horts. These studies should ideally include repeated mea-
surements of both disease-related constructs and actigraphy
to gain more insight in potentially bi-directional associa-
tions. Second, studies have reported successful improve-
ment of circadian rhythms and mental health after interven-
tions focused on the 24-h rhythm, but effects on somatic
conditions are largely unclear. Well-controlled intervention
trials that integrate actigraphy and have longer follow-up
periods will be needed to assess whether treatment of dis-
turbed 24-h activity rhythms can reduce disease burden or
even alter disease progression or incidence. This could also
provide information for any potential preventive effects of
targeting 24-h activity rhythm disturbances. Lastly, as new
studies become available with high speed, well-executed
meta-analyses will be needed to direct the field. For this
aim, a standardized approach using the same estimates and
methods between studies will be highly beneficial.
Conclusion
The 24-h activity rhythm is disturbed in a broad range of
age-related diseases. In neurodegenerative disease, psy-
chiatric disease, cardio-metabolic disease, and cancer, pa-
tients have more phase shifts, lower amplitudes, more
fragmented, and less stable 24-h activity rhythms. An in-
creasing number of longitudinal studies suggest that these
disturbed 24-h activity rhythms may also precede disease,
but causality remains to be determined. The need for lon-
gitudinal observational studies remains substantial, as
well as the need for investigating promising interventions
for those diseases where circadian disruption could be
involved in disease etiology, symptom maintenance, or
impaired quality of life.
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